WHO ICTRP trial
A Single-Arm, Multi-Centre Phase II/III Study to Evaluate the Efficacy, Safety…
ChiCTR2300079267 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2300079267 |
|---|---|
| Public title | A Single-Arm, Multi-Centre Phase II/III Study to Evaluate the Efficacy, Safety, Pharmacokinetic, and Immunogenicity of KJ103 for Desensitisation Therapy in Highly Sensitised Kidney Transplant Patients. |
| Scientific title | A Single-Arm, Multi-Centre Phase II/III Study to Evaluate the Efficacy, Safety, Pharmacokinetic, and Immunogenicity of KJ103 for Desensitisation Therapy in Highly Sensitised Kidney Transplant Patients. |
| Primary sponsor | Huazhong University of Science & Technology/ Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 2-3 |
| Countries | China |
| Conditions | organ transplantation |
| Interventions | KJ103 Treatment Group:0.25 mg/kg KJ103 |
| Registration date | Dec 28, 2023 |
| Target size | KJ103 Treatment Group:33 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: